Medicines
- Bizengri zenocutuzumab · No generic yet Advanced bile duct cancer with an NRG1 gene fusion
- Imfinzi durvalumab · No generic yet Biliary tract cancer (bile ducts and gallbladder)
- Keytruda pembrolizumab · No generic yet Stomach, esophagus, bile duct and some liver and colorectal cancers
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Stomach, esophagus, bile duct and some liver and colorectal cancers
- Lytgobi futibatinib · No generic yet Bile duct cancer in the liver with FGFR2 gene changes
- Pemazyre pemigatinib · No generic yet Bile duct cancer (cholangiocarcinoma) with an FGFR2 change
- Tibsovo ivosidenib · No generic yet Bile duct cancer (cholangiocarcinoma) with an IDH1 mutation
- Ziihera zanidatamab-hrii · No generic yet HER2-positive cancer of the bile ducts or gallbladder
From each medicine’s FDA label. Only your prescriber can say which one is right for you, and many are prescribed for other reasons too.